Replimune Group, Inc. (CIK: 0001737953) EDGAR, Information, Filings... CompaniesBIO.Com

Replimune Group, Inc.

Mailing address
500 UNICORN PARK, WOBURN, Delaware, 01801
Phone
(781) 222-9600
State location
Massachusetts
State of incorporation
Delaware
Fiscal year end
March 31
SIC
2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Filings
N/A

Replimune Group, Inc. (CIK: 0001737953) is an American company incorporated in the state of Massachusetts. Head office is located at 500 UNICORN PARK, WOBURN, Massachusetts, 01801. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). Replimune Group, Inc. is a public company and trade via Over-The-Counter (OTC).

Owner	Filings	Transaction Date	Type of Owner
Sarchi Christopher	0001986597	Jul-17-2023	officer: Chief Commercial Officer
Peeples-Dyer Veleka	0001978705	Jun-01-2023	director
Schwendenman Andrew	0001977879	May-18-2023	officer: Chief Accounting Officer
Xynos Konstantinos	0001956241	Dec-01-2022	officer: Chief Medical Officer
Oliger Christy J.	0001822092	Dec-01-2021	director
Patel Sushil	0001860609	May-03-2021	officer: Chief Commercial Officer
Lewis Tanya	0001451038	Nov-02-2020	director
Pirzkall Andrea	0001818578	Jul-20-2020	officer: Chief Medical Officer
Pucci Paolo	0001436861	Apr-01-2020	director
Franchi Jean M.	0001653053	Dec-09-2019	officer: Chief Financial Officer
Atlas Venture Opportunity Fund I, L.P.	0001759241	Nov-18-2019	other: See Remarks
Atlas Venture Associates Opportunity I, L.P.	0001780065	Nov-18-2019	other: See Remarks
Atlas Venture Associates Opportunity I, LLC	0001780066	Nov-18-2019	other: See Remarks
SLATTERY JOSEPH P	0001246530	Jul-19-2018	director
GORGOL STEPHEN A	0001287980	Jul-19-2018	officer: Chief Accounting Officer
Stampacchia Otello	0001361712	Jul-19-2018	director, 10 percent owner
Levitsky Hyam	0001375792	Jul-19-2018	director
Astley-Sparke Philip	0001376491	Jul-19-2018	director, 10 percent owner, officer: Executive Chairman
Coffin Robert	0001376492	Jul-19-2018	director, 10 percent owner, officer: President and C.E.O.
Love Colin	0001376493	Jul-19-2018	10 percent owner, officer: Chief Operating Officer
Redmile Group, LLC	0001425738	Jul-19-2018	10 percent owner
Dhingra Kapil	0001456849	Jul-19-2018	director
Omega Fund IV, L.P.	0001528382	Jul-19-2018	10 percent owner
Omega Fund IV GP, L.P.	0001528383	Jul-19-2018	10 percent owner
Rhodes Jason P	0001577014	Jul-19-2018	director
Koppel Adam	0001578965	Jul-19-2018	10 percent owner
Lim Richard J.	0001623720	Jul-19-2018	10 percent owner
Omega Fund IV G.P. Manager, Ltd.	0001624456	Jul-19-2018	10 percent owner
Atlas Venture Fund X, L.P.	0001628098	Jul-19-2018	10 percent owner
Green Jeremy	0001650527	Jul-19-2018	10 percent owner
Paster Anne-Mari	0001652863	Jul-19-2018	10 percent owner
Bain Capital Life Sciences Fund, L.P.	0001687968	Jul-19-2018	10 percent owner
BCIP Life Sciences Associates, LP	0001702921	Jul-19-2018	10 percent owner
Schwartz Jeffrey Lawrence	0001702957	Jul-19-2018	10 percent owner
Bain Capital Life Sciences Partners, LP	0001703030	Jul-19-2018	10 percent owner
Bain Capital Life Sciences Investors, LLC	0001703031	Jul-19-2018	10 percent owner
Atlas Venture Associates X, LLC	0001742765	Jul-19-2018	10 percent owner
ATLAS VENTURE ASSOCIATES X, L.P.	0001742766	Jul-19-2018	10 percent owner
Weinand Dieter	0001744419	Jul-19-2018	director
Kaufman Howard	0001744424	Jul-19-2018	officer: Chief Medical Officer
Esposito Pamela	0001744425	Jul-19-2018	officer: Chief Business Officer
Slootweg Hugo Alexander	0001744922	Jul-19-2018	director, 10 percent owner
Forbion Capital Fund III Cooperatief U.A.	0001747586	Jul-19-2018	10 percent owner

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Replimune Group, Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
424B5	Document	Prospectus filed pursuant to Rule 424(b)(5) Acc-no: 0001104659-24-122298 (33 Act) Size: KB	Nov-25-2024	333-273633 241491799
8-K	Document	Current report filing Acc-no: 0001104659-24-121616 (34 Act) Size: KB	Nov-21-2024	001-38596 241485634
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-24-121188 ( Act) Size: 0 KB	Nov-20-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-24-121187 ( Act) Size: 0 KB	Nov-20-2024
S-8	Document	Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Acc-no: 0001104659-24-120636 (33 Act) Size: KB	Nov-19-2024	333-283344 241477292
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001104659-24-118977 (34 Act) Size: KB	Nov-14-2024	005-90574 241462749
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000080255-24-001440 (34 Act) Size: KB	Nov-14-2024	005-90574
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001193125-24-258031 (34 Act) Size: KB	Nov-14-2024	005-90574 241457408
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001193125-24-257984 (34 Act) Size: KB	Nov-14-2024	005-90574 241457071
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000932471-24-001154 (34 Act) Size: KB	Nov-12-2024	005-90574 241449398
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001737953-24-000015 (34 Act) Size: KB	Nov-12-2024	001-38596 241443646
8-K	Document	Current report filing Acc-no: 0001104659-24-116413 (34 Act) Size: KB	Nov-12-2024	001-38596 241443545
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000932471-24-000693 (34 Act) Size: KB	Nov-04-2024	005-90574 241422429
S-8	Document	Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Acc-no: 0001104659-24-109262 (33 Act) Size: KB	Oct-16-2024	333-282682 241375346
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000895421-24-000462 (34 Act) Size: KB	Oct-07-2024	005-90574 241358253
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-24-097495 ( Act) Size: 0 KB	Sep-05-2024
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0001104659-24-097492 ( Act) Size: 0 KB	Sep-05-2024
8-K	Document	Current report filing Acc-no: 0001104659-24-097365 (34 Act) Size: KB	Sep-05-2024	001-38596 241281404
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-24-095834 ( Act) Size: 0 KB	Aug-30-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-24-090980 ( Act) Size: 0 KB	Aug-19-2024

Recent 20 filings. View all Replimune Group, Inc. filings

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Replimune Group, Inc. overview
Replimune Group, Inc. job
Replimune Group, Inc. stock
Replimune Group, Inc. ownership
Replimune Group, Inc. CEO
Replimune Group, Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.